XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Jul. 30, 2023
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three and nine-month periods ended July 30, 2023, and July 31, 2022.


    Three Months Ended     Nine Months Ended  
   
July 30,
2023
    
July 31,
2022
    
July 30,
2023
   
July 31,
2022
 
Expense reported in:
                        
     Cost of goods sold
  
$
322
    
$
303
     $ 892     $ 628  
     Selling, general, and administrative
    
1,499
      
1,115
       4,407       3,539  
     Research and development
    
222
      
163
       575       456  
Total expense incurred
  
$
2,043
    
$
1,581
     $ 5,874     $ 4,623  
                                 
Expense by award type:
                                
     Restricted stock awards
  
$
2,043
    
$
1,506
     $ 5,782     $ 4,189  
     Stock options
    
-
      
20
       1       279  
     Employee stock purchase plan
    
-
      
55
       91       155  
Total expense incurred
 
$
2,043
    
$
1,581
     $ 5,874     $ 4,623  
                                 
Income tax benefits of share-based compensation
  
$
152
    
$
135
     $ 513     $ 323  
Share-based compensation cost capitalized
  
$
-
    
$
-
     $ -     $ -  
Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three and nine-month periods ended July 30, 2023, and July 31, 2022.


   
Three Months Ended
     Nine Months Ended  
   
July 30,
2023
    
July 31,
2022
    
July 30,
2023
    
July 31,
2022
 
Number of shares granted in period
    
-
      
107,824
       786,500       643,224  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
-
    
$
15.95
     $ 16.77     $ 18.72  
Compensation cost not yet recognized
  
$
14,511
    
$
10,256
     $ 14,511     $ 10,256  
Weighted-average amortization period for cost not yet recognized (in years)
    
2.9
      
2.8
       2.9       2.8  
Shares outstanding at balance sheet date
    
1,267,247
      
916,554
       1,267,247       916,554  
Stock Options Activity The table below presents information on our stock options for the three and nine-month periods ended July 30, 2023, and July 31, 2022.


   
Three Months Ended
     Nine Months Ended
  
   
July 30,
2023
    
July 31,
2022
    
July 30,
2023
    
July 31,
2022
  
Number of options granted in period
    
-
      
-
       -       -  
Cash received from options exercised
  
$
512
    
$
1,007
     $ 1,094     $ 5,157  
Compensation cost not yet recognized
  
$
-
    
$
33
     $ -     $ 33  
Weighted-average amortization period for cost not yet recognized (in years)
    
-
      
0.5
      
-
       0.5  
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of July 30, 2023, is presented below.

Options
  
Shares
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (in years)
    
Aggregate
Intrinsic
Value
  
Outstanding and exercisable at July 30, 2023
    
473,300
    
$
10.17
      
2.80
    
$
7,600